Search Results 1491-1500 of 10311 for total t4

  1. Hematology - Clinical trials

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS) ...

  2. Nedosiran in Pediatric Patients from Birth to 5 Years of Age with PH and Relatively Intact Renal Function - Mayo Clinic

    ... total bilirubin > 2 × ULN or INR > 1.5 3. Severe flu-like symptoms leading to discontinuation of therapy 4. Localized skin reaction from the injection ...

  3. A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea - Mayo Clinic

    A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), ...

  4. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  5. Study to Evaluate the Pathophysiology of Multiple System Atrophy, Parkinson's Disease, Parkinson's Disease with Autonomic Failure and Dementia with Lewy Bodies Using Microneurographic Recordings of Muscle Sympathetic Nerve Activity - Mayo Clinic

    The presence of OH (fall in SBP ≥ 30 mmHg) or urinary incontinence (persistent involuntary partial or total bladder emptying, accompanied by erectile ...

  6. Clinical trials - Oncology (Medical)

    The overall goal of this study is to understand if adding inotuzumab ozogamicin to standard of care chemotherapy maintains or improves outcomes in High Risk ...

  7. Continued Access To PREVAIL (CAP2) - Mayo Clinic

    The subject is unable to complete follow-up visits for the duration of the study. Echo Exclusion Criteria: A subject is excluded from the study if any of the ...

  8. Gastroenterology and Hepatology - Clinical trials

    ... overall histopathological reading and no worsening of liver fibrosis on NASH Clinical Research Network (CRN) fibrosis score. Resolution of NASH is defined ...

  9. Treatment

    Ependymoma treatment options include: Surgery. Brain surgeons, called neurosurgeons, work to remove as much of the ependymoma as possible.

  10. A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, And Elotuzumab, Pomalidomide, And Dexamethasone Or Pomalidomide, Bortezomib, And Dexamethasone In Participants With Relapsed Or Refractory Myeloma Who Have Received An Anti-CD38 Antibody And Lenalidomide - Mayo Clinic

    If either is suspected, negative whole brain magnetic resonance imaging (MRI) and lumbar cytology are required. Note: Other protocol defined Inclusion ...